• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMichael Pearson

Michael Pearson

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company
By Lucinda ShenJuly 13, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Valeant’s Former CEO Will Stay on as an $83,000-a-Month Consultant
By Lucinda ShenMay 31, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance
Ackman Bids Farewell to Man Who Pushed for Disastrous Valeant Investment
By Laura LorenzettiMay 12, 2016
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
Finance
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
Fortune Global Forum 2015
Leadership
Meet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
Squawk Box - Season 20
Finance
Bill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
Valeant’s CEO Just Avoided Contempt Charges From the U.S. Senate
By ReutersApril 13, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
By Jen WiecznerMarch 18, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Here’s Why Valeant Shares Plummeted Again
By Laura LorenzettiMarch 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Valeant’s Shares Are Having An Epically Bad Day
By Jen WiecznerMarch 15, 2016
Inside The 2016 Consumer Electronics Show
Finance
These Stock Market-Battered Execs Just Became Ex-Billionaires
By Robert HackettJanuary 26, 2016
valeant ceo michael pearson
Leadership
Valeant’s CEO Isn’t Sure When He’ll Return from Medical Leave
By ReutersJanuary 25, 2016
Janet Yellen Testifies Before House Financial Services Committee
Finance
End of Easy Money Brings Relief
By Alan MurrayDecember 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant accounting scandal: 4 critical questions that have been left unanswered
By Stephen GandelOctober 26, 2015
1
  • 1
1
Most Popular
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.